Literature DB >> 20132259

Epidemiological markers of Streptococcus pyogenes strains in Tunisia.

M Hraoui1, I Boutiba-Ben Boubaker, A Doloy, E Samir, S Ben Redjeb, A Bouvet.   

Abstract

To further understand the epidemiology of Streptococcus pyogenes or group A streptococcus (GAS) infections in Tunisia, phenotypic and genomic markers of GAS isolates, including antibiotic susceptibility, biotypes, T and emm types and toxin gene profiles, have been characterized. A total of 103 isolates, collected between 2000 and 2006, were investigated; 47 were recovered from invasive infections, and 56 from non-invasive infections. Rates of resistance to tetracycline, erythromycin, clindamycin and rifampin were 70.8%, 4.8%, 4.8% and 0.9%, respectively. High levels of resistance to streptomycin and kanamycin were observed in 1.9% and 4.8% of isolates, respectively. Biotype 3 was most common. Twenty different T patterns were observed, with a predominance of T3/13/B3264, and 38 different emm types. In both invasive and non-invasive isolates, emm118 (9.7%), emm42 (8.7%), emm1 (7.8%), st432 (6.8%), emm28 (5.8%) and emm76 (5.8%) were the most prevalent types; emm1, emm76 and emm18 were mainly observed among invasive infections, whereas emm118 (12.5%), emm42 (10.7%) and emm28 (8.9%) were predominant among non-invasive infections. The speB gene was detected in all isolates, but there were variable frequencies of speA, speC and ssa (20.3%, 32% and 25.2% respectively). Significant associations of emm1, emm18 and emm3 with speA and of emm4 and st432 with ssa were found. This first report from Tunisia revealed a unique emm distribution of GAS that differs from those of other regions. This information on the distribution of such emm types will be useful for the development of an appropriate vaccine in a country where the incidence of rheumatic fever remains high.
© 2010 The Authors. Journal Compilation © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20132259     DOI: 10.1111/j.1469-0691.2010.03174.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  6 in total

1.  Community outbreak of invasive group A streptococcus infection in Ontario, Canada.

Authors:  C Dickson; M T Pham; V Nguyen; C Brubacher; M S Silverman; K Khaled; G Hovhannisyan
Journal:  Can Commun Dis Rep       Date:  2018-07-05

2.  Rationale and design of the African group A streptococcal infection registry: the AFROStrep study.

Authors:  Dylan D Barth; Mark E Engel; Andrew Whitelaw; Alemseged Abdissa; Wilson E Sadoh; Sulafa K M Ali; Samba O Sow; James Dale; Bongani M Mayosi
Journal:  BMJ Open       Date:  2016-02-25       Impact factor: 2.692

3.  Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal emm Clusters in Africa To Inform Vaccine Development.

Authors:  Taariq Salie; Kelin Engel; Annesinah Moloi; Babu Muhamed; James B Dale; Mark E Engel
Journal:  mSphere       Date:  2020-07-15       Impact factor: 4.389

4.  PASCAR and WHF Cardiovascular Diseases Scorecard project.

Authors:  Habib Gamra; Jihene Maatoug; Jean M Fourie; Wihan Scholtz; Oana Scarlatescu; George Nel; Hassen Ghannem
Journal:  Cardiovasc J Afr       Date:  2020 Sep/Oct       Impact factor: 1.167

5.  Antibiotic prescription preferences in paediatric outpatient setting in Estonia and Sweden.

Authors:  Jana Lass; Viveca Odlind; Alar Irs; Irja Lutsar
Journal:  Springerplus       Date:  2013-03-21

6.  Molecular Epidemiology of Noninvasive and Invasive Group A Streptococcal Infections in Cape Town.

Authors:  D D Barth; P Naicker; K Engel; B Muhamed; W Basera; B M Mayosi; J B Dale; M E Engel
Journal:  mSphere       Date:  2019-10-30       Impact factor: 4.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.